Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: Implications for HIV-1 vaccine efficacy trials

被引:0
|
作者
Baeten, JM
Richardson, BA
Martin, HL
Nyange, PM
Lavreys, L
Ngugi, EN
Mandaliya, K
Ndinya-Achola, JO
Bwayo, JJ
Kreiss, JK
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98104 USA
[3] Univ Washington, Dept Med, Seattle, WA 98104 USA
[4] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[5] Univ Nairobi, Dept Community Hlth, Nairobi, Kenya
[6] Coastal Prov Gen Hosp, Mombasa, Kenya
关键词
HIV-1; incidence; vaccine; prostitutes; sexual behavior; STD; Africa;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Accurate predictions of HIV-1 incidence in potential study populations are essential for designing HIV-1 vaccine efficacy trials. Little information is available on the estimated incidence of HIV-I in such populations, especially information on incidence over time and incidence while participating in risk-reduction programs. Objectives: To examine time trends in HIV-1 incidence in a vaccine preparedness cohort. Design: Prospective cohort study of female prostitutes in Mombasa, Kenya. Methods: HIV-1 incidence was determined using open and closed cohort designs. Generalized estimating equations were used to model HIV-1 and sexually transmitted disease (STD) incidence and sexual risk behaviors over time. Results: When analyzed as a closed cohort, HIV-1 incidence declined 10-fold during 3 years of follow-up (from 17.4 to 1.7 cases/100 person-years; p <.001). More than 50% of the cases of HIV-1 occurred during the first 6 months after enrollment, and 73% during the first 12 months. When analyzed as an open cohort, HIV-1 incidence density fell during the first 4 calendar years, influenced by accumulation of lower risk participants and variations in study recruitment. Significant declines occurred in both STD incidence and high-risk sexual behaviors during follow-up. Conclusions: This study documents a dramatic decline in the risk of HIV-1 infection while participating in a prospective cohort, with most seroconversions occurring within 1 year of enrollment. Variations in HIV-1 incidence within high-risk populations should be anticipated during the design of vaccine trials.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 50 条
  • [31] Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand - Implications for vaccine trials
    Buchacz, K
    Hu, DJ
    Vanichseni, S
    Mock, PA
    Chaowanachan, T
    Srisuwanvilai, LO
    Gvetadze, R
    van Griensven, F
    Tappero, JW
    Kitayaporn, D
    Kaewkungwal, J
    Choopanya, K
    Mastro, TD
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) : 853 - 860
  • [32] Provision of treatment in HIV-1 vaccine trials in developing countries
    Fitzgerald, DW
    Pape, JW
    Wasserheit, JN
    Counts, GW
    Corey, L
    [J]. LANCET, 2003, 362 (9388): : 993 - 994
  • [33] Identifying barriers to participation in prophylactic HIV-1 vaccine trials
    Peters, BS
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (02) : 73 - 73
  • [34] The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials
    Powell, Rebecca
    Barengolts, Denis
    Mayr, Luzia
    Nyambi, Phillipe
    [J]. VIRUSES-BASEL, 2010, 2 (02): : 639 - 654
  • [35] Prophylactic HIV-1 vaccine trials: past, present, and future
    Nkolola, Joseph P.
    Barouch, Dan H.
    [J]. LANCET HIV, 2024, 11 (02): : e117 - e124
  • [36] Correlates of Attrition Among MSM Followed in a HIV-1 Vaccine Feasibility Cohort Study in Kenya
    Wahome, Elizabeth
    Graham, Susan M.
    Thiong'o, Alexander N.
    Mohamed, Khamisi
    Oduor, Tony
    Gichuru, Evans
    Mwambi, John
    Price, Matt A.
    Sanders, Eduard J.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 257 - 257
  • [37] HIV-1 IN SOMALIA - PREVALENCE AND KNOWLEDGE AMONG PROSTITUTES
    CORWIN, AL
    OLSON, JG
    OMAR, MA
    RAZAKI, A
    WATTS, DM
    [J]. AIDS, 1991, 5 (07) : 902 - 904
  • [38] HIV-1 SEROPREVALENCE IN MALE PROSTITUTES IN NORTHEAST ITALY
    TIRELLI, U
    VACCHER, E
    BULLIAN, P
    SARACCHINI, S
    ERRANTE, D
    BULLIAN, P
    ZAGONEL, V
    SERRAINO, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1988, 1 (04): : 414 - 415
  • [39] Immunogenicity and Efficacy of a Therapeutic HIV-1 Vaccine (HIVAX™) in HIV Patients on HAART
    Tung, F.
    Tung, J. K.
    Castro, J.
    Boliva, H.
    Fischl, M. A.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A173 - A173
  • [40] Implications of HIV diversity for the HIV-1 pandemic
    Hemelaar, Joris
    [J]. JOURNAL OF INFECTION, 2013, 66 (05) : 391 - 400